BALAMINES:NSE2026-10-07
Balaji Amines — Deep Dive Analysis
Q1 FY27 PAT up 111% with margins at 26%, but volumes fell 22% YoY - the recovery is price-led, not demand-led. The stock is up 66% in a year, trades above the average analyst price target, and carries a September 2026 SEBI warning for non-disclosure of a DGFT blacklisting and an FDA warning. Rating: CAUTION - fully valued.